Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $27.5 million.

  • Bio-Techne's Net Cash Flow rose 70809.2% to $27.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$16.2 million, marking a year-over-year decrease of 13602.93%. This contributed to the annual value of -$1.5 million for FY2025, which is 9420.73% up from last year.
  • Bio-Techne's Net Cash Flow amounted to $27.5 million in Q4 2025, which was up 70809.2% from -$16.0 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Net Cash Flow registered a high of $54.4 million during Q2 2023, and its lowest value of -$46.9 million during Q1 2022.
  • Over the past 5 years, Bio-Techne's median Net Cash Flow value was $5.6 million (recorded in 2022), while the average stood at $650600.0.
  • Per our database at Business Quant, Bio-Techne's Net Cash Flow tumbled by 60610.42% in 2023 and then skyrocketed by 70809.2% in 2025.
  • Over the past 5 years, Bio-Techne's Net Cash Flow (Quarter) stood at $12.4 million in 2021, then plummeted by 163.62% to -$7.9 million in 2022, then tumbled by 177.2% to -$22.0 million in 2023, then surged by 79.4% to -$4.5 million in 2024, then soared by 708.09% to $27.5 million in 2025.
  • Its Net Cash Flow was $27.5 million in Q4 2025, compared to -$16.0 million in Q3 2025 and $8.2 million in Q2 2025.